Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-High Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00765245
What this trial is testing

Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Vanderbilt-Ingram Cancer Center 44
Testing effectiveness (Phase 2)Study completedNCT00006241
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fred Hutchinson Cancer Center
Not applicableNot Yet RecruitingNCT07463456
What this trial is testing

Inter-Device Concordance of Plantar Thermal Asymmetry Measurement (HIK-DM-2026)

Who this might be right for
Diabetes Mellitus
Eduardo Luis Martín Javier 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04197141
What this trial is testing

Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 58
Not applicableLooking for participantsNCT07423988
What this trial is testing

Evaluation of Changes in Sleep Efficiency Among PIC DU MIDI Staff Between Nights Spent at Home and Nights Spent in the Workplace Under High Altitude Conditions

Who this might be right for
Sleep Disorder (Disorder)
University Hospital, Toulouse 32
Not applicableNot Yet RecruitingNCT06641661
What this trial is testing

NPC1L1 Gene Polymorphism and the Efficacy and Safety of Hybutimibe

Who this might be right for
Gene PolymorphismASCVD
Qianfoshan Hospital 1,000
Not applicableNot Yet RecruitingNCT07366242
What this trial is testing

Prognostic Value of (DHODH) Expression in (HGSOC): A Comparative Study Between Neoadjuvant and Adjuvant Chemotherapy Settings

Who this might be right for
HGSOC
Heba Ahmed Mohamed 72
Not applicableNot Yet RecruitingNCT06471062
What this trial is testing

Transit Time Flow Measurement in Coronary Surgery

Who this might be right for
Coronary Artery DiseaseCoronary StenosisCoronary Bypass Graft Stenosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 135
Large-scale testing (Phase 3)Active Not RecruitingNCT01368588
What this trial is testing

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 2,590
Not applicableLooking for participantsNCT07343349
What this trial is testing

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions

Who this might be right for
Prostate Cancer Patients Undergoing External Radiation and Seed ImplantationHigh Risk Localised Prostate CarcinomaLocally Advanced Prostate Cancer+1 more
Rigshospitalet, Denmark 1,016
Not applicableLooking for participantsNCT07356115
What this trial is testing

Association of High PainDETECT Scores With Pain Region and Diagnosis in Patients Attending a Musculoskeletal and Sports Medicine Clinic

Who this might be right for
Musculoskeletal PainNeuropathic Pain
Uskudar University 150
Not applicableStudy completedNCT04537247
What this trial is testing

A Comparative Study Between Open and Robotic Partial Nephrectomy in Treatment of High Complex Renal Tumors.

Who this might be right for
Renal Tumor
Assiut University 64
Not applicableUnknownNCT04514276
What this trial is testing

Inter- and Multidisciplinary, Cross-sectoral Feto-neonatal Pathway

Who this might be right for
Pre-EclampsiaIntrauterine Growth RestrictionMaternal Care for Known or Suspected Poor Fetal Growth
Technische Universität Dresden 828
Not applicableWithdrawnNCT05811468
What this trial is testing

Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients

Who this might be right for
Transplant;Failure,KidneyKidney TransplantKidney Rejection Transplant
Rush University Medical Center
Not applicableUnknownNCT02296697
What this trial is testing

Low-level Laser Therapy Versus High Frequency on Pressure Ulcers Treatment

Who this might be right for
Pressure Ulcer
Hospital de Clinicas de Porto Alegre 75
Testing effectiveness (Phase 2)UnknownNCT02342054
What this trial is testing

Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospital de Cruces 49
Testing effectiveness (Phase 2)Study completedNCT00542490
What this trial is testing

Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer

Who this might be right for
Endometrial CancerPapillary SerousClear Cell Endometrial Cancer
University of Oklahoma 23
Not applicableStudy completedNCT01314313
What this trial is testing

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk

Who this might be right for
Symptomatic Severe Aortic Stenosis
Edwards Lifesciences 2,032
Large-scale testing (Phase 3)Active Not RecruitingNCT04824092
What this trial is testing

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

Who this might be right for
Diffuse Large B-cell Lymphoma
Incyte Corporation 899
Testing effectiveness (Phase 2)Looking for participantsNCT07259707
What this trial is testing

Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML

Who this might be right for
Acute Myeloid LeukemiaFLT3 Internal Tandem Duplication PositiveIntermediate Risk Acute Myeloid Leukemia+1 more
First Affiliated Hospital of Zhejiang University 25
Next Page